A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation
Open Access
- 19 August 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-19
Abstract
Bronchopulmonary dysplasia (BPD) is a chronic lung disease of prematurity. Exposure to noxious stimuli such as hyperoxia, volutrauma, and infection in infancy can have long-reaching impacts on lung health and predispose towards the development of conditions such as chronic obstructive pulmonary disease (COPD) in adulthood. BPD and COPD are both marked by lung tissue degradation, neutrophil influx, and decreased lung function. Both diseases also express a change in microbial signature characterized by firmicute depletion. However, the relationship between pulmonary bacteria and the mechanisms of downstream disease development has yet to be elucidated. We hypothesized that murine models of BPD would show heightened acetylated proline-glycine-proline (Ac-PGP) pathway and neutrophil activity, and through gain- and loss-of-function studies we show that Ac-PGP plays a critical role in driving BPD development. We further test a inhaled live biotherapeutic (LBP) using active Lactobacillus strains in in vitro and in vivo models of BPD and COPD. The Lactobacillus-based LBP is effective in improving lung structure and function, mitigating neutrophil influx, and reducing a broad swath of pro-inflammatory markers in these models of chronic pulmonary disease via the MMP-9/PGP (matrix metalloproteinase/proline-glycine-proline) pathway. Inhaled LBPs show promise in addressing common pathways of disease progression that in the future can be targeted in a variety of chronic lung diseases.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K08 HL141652, R35HL135710, R35HL166433, R01HL156275, R44HL164156)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute
This publication has 47 references indexed in Scilit:
- Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the LungCell, 2019
- Airway Microbiome and Development of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic ReviewThe Journal of Pediatrics, 2019
- Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiologyRespiratory Medicine, 2017
- Elastase-Induced Lung Emphysema Models in Mice2017
- The respiratory tract microbiome and lung inflammation: a two-way streetMucosal Immunology, 2016
- Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiencyNature Communications, 2016
- Matrikines are key regulators in modulating the amplitude of lung inflammation in acute pulmonary infectionNature Communications, 2015
- Extraction of Cell Wall-Bound Teichoic Acids and Surface Proteins from Listeria monocytogenes2012
- A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammationNature Medicine, 2006
- Inhaled corticosteroids for stable chronic obstructive pulmonary disease2001